RxDoctor Payments Data

Richard Oberlander, DO

Internal Medicine · Columbus, OHNPI 1477581189

Payments from drug & device makers

$605in general payments, 2019–2025

Across 93 payments — averaging $6.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$377
  • Boehringer Ingelheim$184
  • AbbVie$15
  • Amgen$15
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$14

What the payments were for

  • Food & beverage$45175%
  • Education$15425%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$605 in reported general payments places this provider in the 65th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$192,848
Medicare patients
424
Services billed
2,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban243$203,541
OzempicSemaglutide126$130,793
JardianceEmpagliflozin120$129,872
Synjardy XrEmpagliflozin/Metformin Hcl64$42,567
XareltoRivaroxaban46$39,798
FarxigaDapagliflozin Propanediol46$37,991
Trijardy XrEmpaglifloz/Linaglip/Metformin51$37,511
Breztri AerosphereBudesonide/Glycopyr/Formoterol37$30,464
MounjaroTirzepatide25$27,558
GlyxambiEmpagliflozin/Linagliptin21$23,880
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$19,289
EntrestoSacubitril/Valsartan17$16,660
TradjentaLinagliptin14$14,126
Tresiba Flextouch U-100Insulin Degludec16$11,571
SynjardyEmpagliflozin/Metformin Hcl16$11,523

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr, Glyxambi, Tradjenta$184$259,478286 claims
AbbVieRestasis, Synthroid$15$11,102111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →